IBM, the No. 2 U.S. computer company, unveiled an advanced analytical software and services tool that used its powerful Watson supercomputer.
Drugs maker AstraZeneca is to cut 1,150 jobs in the U.S. with the intention of streamlining the business.
British scientists have made the first human embryonic stem cells of a high enough grade to use in patients and deposited them in a public stem cell bank for development in human trials by drug companies and researchers by 2014.
Britain will promote use of new medicines and has earmarked 180 million pounds ($280 million) to bring modern technologies to market under a package of reforms designed to make the country more attractive to big pharmaceuticals companies.
Dozens of adult stem cell treatments are moving through clinical trials and showing early success, raising hopes that some could reach the market within five years.
Stock index futures rose sharply on Friday after a report the European Central Bank was gearing up to lend money to the International Monetary Fund in a bid to ease the Eurozone debt crisis.
Stock index futures pointed to a sharply higher open for equities on Wall Street Friday, with futures for the S&P 500, for the Dow Jones and for the Nasdaq 100 up 1 to 1.1 percent ahead of a key jobs report.
Three prominent United States senators wrote a letter to numerous drug makers Thursday, inquiring about Pfizer Inc.'s deals with insurers and pharmacy benefit managers that might limit the market for the selling of generic versions of the company's Lipitor cholesterol drug.
Ranbaxy Laboratories said on Thursday it has launched the first generic version of the cholesterol-lowering Lipitor in the U.S., the largest selling drug of all time, sending its shares surging over 11 percent.
Stock index futures pointed to a weaker open on Wall Street on Thursday, with futures for the S&P 500 down 0.5 percent, Dow Jones futures down 0.4 percent and Nasdaq 100 futures down 0.2 percent at 4:37 a.m. ET.
As cholesterol fighter Lipitor goes generic, its maker Pfizer Inc is hoping to hold onto perhaps a third of the 3 million Americans who take the biggest-selling drug of all time.
Pfizer Inc. will see the end of a hugely lucrative era on Wednesday, Nov. 30, when its two-decade old patent for Lipitor, a hugely popular drug for cholesterol management, expires.
U.S-based multinational corporations added almost 3 million jobs to their payrolls in foreign countries between 1999 and 2009, while slashing 864,600 jobs at home, as they become increasingly dependent on foreign sales. Is tax holiday a viable solution?
Kenneth Kies sizes up the chances of reforming the convoluted U.S. tax code like someone who has lived through it before. In fact, he has.
Pfizer Inc. agreed to buy privately held biopharmaceutical company Excaliard Pharmaceuticals for an undisclosed sum, to gain access to Excaliard's experimental skin scarring drug.
More people than ever are living with the AIDS virus but this is largely due to better access to drugs that keep HIV patients alive and well for many years, the United Nations AIDS program (UNAIDS) said on Monday.
Pfizer Inc won expert backing for using its blockbuster vaccine in adults to fight pneumonia, meningitis and other diseases caused by pneumococcus bacteria.
Pfizer Inc won expert backing for using its blockbuster vaccine in adults to fight pneumonia, meningitis and other diseases caused by pneumococcus bacteria.
Members of Congress' super committee responsible for slicing $1.2 trillion from the deficit have faced an intense lobbying push since being appointed to the 12-member panel, but they all have long histories of accepting money from the industries and special interest groups clamoring for a seat at the table.
Hedge fund manager David Einhorn exited Pfizer
, his largest holding, and made new bets on CBS Corp ., General Motors Co and Marvell Technology Group during the third quarter.
Americans in the past year got access to 24 new medicines before they became available anywhere else, U.S. drug regulators said.
Britain's GlaxoSmithKline has agreed to pay billions of dollars to settle multiple U.S. pharmaceutical investigations.